News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
byMike Ng
Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
COVID-19 vaccines remain effective against severe outcomes
17 Oct 2025
byElvira Manzano
Even as COVID-19 severity wanes and public uptake declines, previous receipt of the 2024-2025 COVID vaccines continues to reduce emergency visits, hospital stays, and deaths among US veterans, as shown in a recent study.
COVID-19 vaccines remain effective against severe outcomes
17 Oct 2025
High burden of asthma readmission seen in preschool children
16 Oct 2025
byStephen Padilla
Asthma readmission is highly prevalent among preschool children, reveals an Australia study, noting the need to identify modifiable factors such as asthma management after discharge to ease the burden of hospital readmission in this population.






